← Scroll for more →
Inmune Bio, Inc. (INMB)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.45
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.77
P/B Ratio
1.89
Institutional Ownership
15.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 706.4K | $1.0M | 2.55% | +19.4K | 2026-06-30 |
| AQR Capital Management LLC | 662.2K | $1.0M | 2.39% | +391.9K | 2026-06-30 |
| BlackRock, Inc. | 311.6K | -- | 1.13% | -882.5K | 2026-06-30 |
| Raymond James Financial Inc | 213.0K | -- | 0.77% | +9.8K | 2026-06-30 |
| Geode Capital Management, LLC | 190.2K | -- | 0.69% | -304.8K | 2026-06-30 |
| Goldman Sachs Group Inc | 185.2K | -- | 0.67% | -46.3K | 2026-06-30 |
| Millennium Management LLC | 159.6K | -- | 0.58% | +66.9K | 2026-06-30 |
| Jane Street Group, LLC | 134.2K | -- | 0.49% | +69.2K | 2026-06-30 |
| Citadel Advisors LLC | 123.0K | -- | 0.44% | +110.5K | 2026-06-30 |
| UBS Group AG | 110.4K | -- | 0.40% | -142.9K | 2026-06-30 |